Targeting DNA topoisomerase II in cancer chemotherapy

JL Nitiss - Nature Reviews Cancer, 2009 - nature.com
Recent molecular studies have expanded the biological contexts in which topoisomerase II
(TOP2) has crucial functions, including DNA replication, transcription and chromosome …

Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs

S Salerno, F Da Settimo, S Taliani… - Current medicinal …, 2010 - ingentaconnect.com
DNA topoisomerases (topos) are essential enzymes that regulate the topological state of
DNA during cellular processes such as replication, transcription, recombination, and …

Design, synthesis, and biological evaluation of novel 7-substituted 10, 11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in …

G Zhang, R Yin, X Dai, G Wu, X Qi, R Yu, J Li… - European Journal of …, 2022 - Elsevier
A series of novel 7-substituted 10, 11-methylenedioxy-camptothecin (FL118) derivatives
were designed, synthesized, and biologically evaluated. All the FL118 analogues showed …

[HTML][HTML] FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models

X Ling, X Liu, K Zhong, N Smith, J Prey… - American journal of …, 2015 - ncbi.nlm.nih.gov
Irinotecan and topotecan are the only camptothecin analogues approved by the FDA for
cancer treatment. However, inherent and/or acquired irinotecan and topotecan resistance is …

Impact of breast cancer resistance protein on cancer treatment outcomes

DD Ross, T Nakanishi - Multi-drug resistance in cancer, 2010 - Springer
Breast cancer resistance protein (BCRP/ABCG2) was discovered in multidrug resistant
breast cancer cells having an ATP-dependent transport-based resistance phenotype. This …

Metal Complexes as topoisomerase inhibitors

M Gaikwad, VB Konkimalla, S Salunke-Gawali - Inorganica Chimica Acta, 2022 - Elsevier
The topoisomerase family is a group of enzymes that orchestrate DNA topology and is
required to uniform genetic makeup during replication, recombination, and transcription …

Synthesis of novel 10, 11-methylenedioxy-camptothecin glycoside derivatives and investigation of their anti-tumor effects in vivo

G Wu, X Mai, F Liu, M Lin, X Dong, Q Xu, C Hao… - RSC …, 2019 - pubs.rsc.org
10, 11-Methylenedioxy-camptothecin (FL118) is a novel camptothecin analogue that
possesses exceptional antitumor efficacy in human tumor xenograft models. The aim of the …

DNA-binding, topoisomerases I and II inhibition and in vitro cytotoxicity of ruthenium (II) polypyridyl complexes:[Ru (dppz) 2L] 2+(L= dppz-11-CO2Me and dppz)

X He, L Jin, L Tan - Spectrochimica Acta Part A: Molecular and …, 2015 - Elsevier
Two ruthenium (II) polypyridyl complexes,[Ru (dppz) 2 dppz-11-CO 2 Me](ClO 4) 2 (Ru1)
and [Ru (dppz) 3](ClO 4) 2 (Ru2), have been synthesized and characterized. The spectral …

Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program

PJ Houghton, R Gorlick, EA Kolb, R Lock… - Pediatric blood & …, 2012 - Wiley Online Library
Background AZD8055 is a small molecule ATP‐competitive inhibitor of the serine/threonine
kinase mTOR that regulates cap‐dependent translation through the mTORC1 complex and …

Ruthenium (II) polypyridyl complexes with 1, 8-naphthalimide group as DNA binder, photonuclease, and dual inhibitors of topoisomerases I and IIα

Y Sun, J Li, H Zhao, L Tan - Journal of Inorganic Biochemistry, 2016 - Elsevier
Two ruthenium (II) polypyridyl complexes containing 1, 8-naphthalimide group as DNA
binders, photonucleases, and inhibitors of topoisomerases I and IIα are evaluated. The …